Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lassmann

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 11, 2022
Modelling SPECT auto-contouring acquisitions for <sup>177</sup>Lu & <sup>131</sup>I molecular radiotherapy using new developments in Geant4/GATEGunjan Kayal, Maxime Chauvin, Erick Mora-Ramirez, et al.
EJNMMI Physics|August 3, 2018
Inter-comparison of quantitative imaging of lutetium-177 (<sup>177</sup>Lu) in European hospitalsJill Wevrett, Andrew Fenwick, James Scuffham, et al.
International Journal of Radiation Biology|December 9, 2021
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposurePatrick Ostheim, Matthias Miederer, Mathias Schreckenberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
EJNMMI Physics|October 8, 2020
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD projectJan Taprogge, Francesca Leek, Tino Schurrat, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the DetailsGlenn D Flux, Frederik A Verburg, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Radiation Oncology (London, England)|June 23, 2012
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaMichael C Kreissl, Heribert Hänscheid, Mario Löhr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Safety, Biodistribution, and Radiation Dosimetry of <sup>68</sup>Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging StudyGuillaume P Nicolas, Seval Beykan, Hakim Bouterfa, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 11, 2022
Modelling SPECT auto-contouring acquisitions for <sup>177</sup>Lu & <sup>131</sup>I molecular radiotherapy using new developments in Geant4/GATEGunjan Kayal, Maxime Chauvin, Erick Mora-Ramirez, et al.
EJNMMI Physics|August 3, 2018
Inter-comparison of quantitative imaging of lutetium-177 (<sup>177</sup>Lu) in European hospitalsJill Wevrett, Andrew Fenwick, James Scuffham, et al.
International Journal of Radiation Biology|December 9, 2021
mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposurePatrick Ostheim, Matthias Miederer, Mathias Schreckenberger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2022
An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine, Jean-Pierre Pouget, Mark Konijnenberg, et al.
EJNMMI Physics|October 8, 2020
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD projectJan Taprogge, Francesca Leek, Tino Schurrat, et al.
Oncotarget|June 4, 2016
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathyRudolf A Werner, Seval Beykan, Takahiro Higuchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the DetailsGlenn D Flux, Frederik A Verburg, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 12, 2024
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed dosesJean-Pierre Pouget, Pablo Minguez Gabina, Ken Herrmann, et al.
Radiation Oncology (London, England)|June 23, 2012
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaMichael C Kreissl, Heribert Hänscheid, Mario Löhr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Safety, Biodistribution, and Radiation Dosimetry of <sup>68</sup>Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging StudyGuillaume P Nicolas, Seval Beykan, Hakim Bouterfa, et al.
Pageof 17